Literature DB >> 7974913

The effect of active immunization against gonadotropin-releasing hormone on the ultrastructure of the rat ventral prostate.

J Fürst1, E Fiebiger, D Mack, J Frick, E Rovan.   

Abstract

To evaluate the effects of active immunization against gonadotropin-releasing hormone (GnRH) on the ultrastructure of the rat ventral prostate, male Sprague-Dawley rats received three consecutive intramuscular injections of 10 micrograms/100 g body weight (D-Lys6)-GnRH-diphtheria toxoid conjugate (GnRH-DT vaccine). Following immunization, test animals developed sufficiently high antibody titres to block the pituitary gonadal axis. Consequently testosterone values dropped to the levels in castrates. This therapy leads to atrophy of the prostate. Following immunization a strong immunological response, indicating the presence of considerable amounts of a GnRH-like peptide, was observed in the ventral prostates as early as 14 days after the first injection of GnRH-DT. Immunoneutralisation of GnRH-like activity may contribute to the effects observed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7974913     DOI: 10.1007/BF00311001

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  16 in total

1.  Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.

Authors:  P S Rennie; N Bruchovsky; S L Goldenberg; D Lawson; T Fletcher; J A Foekens
Journal:  J Urol       Date:  1988-06       Impact factor: 7.450

2.  Production of antiserum to LH-releasing hormone (LH-RH) associated with gonadal atrophy in rabbits: development of radioimmunoassays for LH-RH.

Authors:  A Arimura; H Sato; T Kumasaka; R B Worobec; L Debeljuk; J Dunn; A V Schally
Journal:  Endocrinology       Date:  1973-11       Impact factor: 4.736

3.  Histopathological changes in reproductive organs of male Wistar rats following active immunization against LHRH.

Authors:  D K Giri; M K Chaudhuri; R Jayashankar; G S Neelaram; S Jayaraman; G P Talwar
Journal:  Exp Mol Pathol       Date:  1990-02       Impact factor: 3.362

4.  Receptors for luteinizing hormone-releasing hormone (LHRH) in Dunning R3327 prostate cancers and rat anterior pituitaries after treatment with a sustained delivery system of LHRH antagonist SB-75.

Authors:  G Srkalovic; L Bokser; S Radulovic; E Korkut; A V Schally
Journal:  Endocrinology       Date:  1990-12       Impact factor: 4.736

5.  Androgens modulate epidermal growth factor receptor levels in the rat ventral prostate.

Authors:  R St-Arnaud; P Poyet; P Walker; F Labrie
Journal:  Mol Cell Endocrinol       Date:  1988-03       Impact factor: 4.102

6.  Recovery of gonadal functions in the adult male rat following cessation of five-month daily treatment with an LHRH agonist.

Authors:  F A Lefebvre; A Bélanger; G Pelletier; F Labrie
Journal:  J Androl       Date:  1984 May-Jun

7.  Effect of active immunization to luteinizing-hormone-releasing hormone on the fertility and histoarchitecture of the reproductive organs of male rat.

Authors:  E Rovan; E Fiebiger; N R Kalla; G P Talwar; W Aulitzky; J Frick
Journal:  Urol Res       Date:  1992

8.  Expression of luteinizing hormone-releasing hormone mRNA in the human prostatic cancer cell line LNCaP.

Authors:  P Limonta; D Dondi; R M Moretti; D Fermo; E Garattini; M Motta
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

9.  Prolactin and luteinizing hormone-releasing hormone receptors in human benign prostatic hyperplasia and prostate cancer.

Authors:  T Kadar; M Ben-David; J E Pontes; M Fekete; A V Schally
Journal:  Prostate       Date:  1988       Impact factor: 4.104

Review 10.  Goserelin acetate implant: a depot luteinizing hormone-releasing hormone analog for advanced prostate cancer.

Authors:  B R Goldspiel; D R Kohler
Journal:  DICP       Date:  1991 Jul-Aug
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.